Cargando…
Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
Autores principales: | Olmedo, Maria, Reigadas, Elena, Valerio, Maricela, Vázquez-Cuesta, Silvia, Pajares, José Antonio, Matilla, Ana, Muñoz, Patricia, Bouza, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441988/ https://www.ncbi.nlm.nih.gov/pubmed/30847461 |
Ejemplares similares
-
Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results
por: Reigadas, Elena, et al.
Publicado: (2018) -
Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention
por: Olmedo, María, et al.
Publicado: (2020) -
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: de la Villa, Sofía, et al.
Publicado: (2023) -
Clostridioides difficile infection epidemiology and clinical characteristics in COVID-19 pandemic
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2022) -
Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)